Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01213732
Brief Title: Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intransit Stage III/IV Melanoma

First Submitted : October 1, 2010
First Submitted that Met QC Criteria : October 1, 2010
First Posted : October 4, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : September 22, 2011
Last Update Posted : September 23, 2011 (Estimate)